A risk assessment report on PMMA (paramethoxymethylamphetamine or N-methyl-1-(4-methoxyphenyl)-2-aminopropane) was drawn up, on the basis of Article 4(3) of Joint Action 97/396/JHA, at a meeting convened under the auspices of the Scientific Committee of the European Monitoring Centre for Drugs and Drug Addiction.
Recital 1, Decision_act (EU) 2002/188
In forcesince 28 Feb 2002
- num:eu=1997/396